Hospital
VHS Harlingen Hospital Company, LLC
VHS Harlingen Hospital Company, LLC was paid $11.85M by Medicaid between Jan 2020 and Dec 2024, across 39 billing codes. Its largest line is 99284, emergency room visit (serious) — 62% of everything it billed.
33Billing provider infoVHS HARLINGEN HOSPITAL COMPANY, LLC
WESLACO, TX 78596
WESLACO, TX 78596
33aNPI1457994188assigned 10/25/2019
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.85M
24GClaims68,559
24DCodes billed39
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#15 of 109
Median peer was paid$1.15M
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 369 | $47K | |
| 2021 | 9,673 | $1.88M | |
| 2022 | 19,500 | $3.07M | |
| 2023 | 23,558 | $5.73M | |
| 2024incomplete | 15,459 | $1.12M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 62% | 6,993 | 6,584 | $7.38M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 20% | 2,159 | 1,974 | $2.39M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.3% | 10,709 | 10,308 | $870K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.0% | 5,444 | 5,233 | $242K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 1,205 | 1,074 | $209K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 6,202 | 5,331 | $166K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,376 | 1,249 | $105K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,333 | 1,290 | $99K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 817 | 712 | $62K |
| 80053 | Comprehensive metabolic panel | <1% | 5,115 | 4,646 | $49K |
| 87430 | <1% | 2,379 | 2,295 | $43K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,352 | 4,877 | $35K |
27 more codes
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 268 | $25K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,592 | $23K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 518 | $20K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 245 | $16K |
| 87081 | <1% | 1,929 | $14K | |
| 71045 | Radiologic examination, chest; single view | <1% | 802 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,553 | $14K |
| 81025 | <1% | 1,629 | $13K | |
| 81003 | <1% | 4,973 | $10K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 494 | $8K |
| 87807 | <1% | 561 | $6K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 29 | $6K |
| 87088 | <1% | 851 | $5K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 64 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 812 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 263 | $5K |
| 84484 | <1% | 921 | $4K | |
| 83690 | <1% | 434 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 63 | $2K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 66 | $1K |
| S0028 | Injection, famotidine, 20 mg | <1% | 163 | $994.37 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 719 | $786.40 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 16 | $687.84 |
| 83605 | <1% | 75 | $367.82 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 14 | $243.71 |
| 84702 | <1% | 13 | $199.29 | |
| A9270 | Non-covered item or service | 0% | 408 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRODRIGUEZ, MARCO (CFO)
| Provider | Location | Paid |
|---|---|---|
| VHS Harlingen Hospital Company LLC | Harlingen, TX | $23.64M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.